New study monitors SPINRAZA's impact on movement in adults with SMA type II
NCT ID NCT04159987
First seen Dec 08, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study follows 20 adults with spinal muscular atrophy (SMA) type II who are already taking SPINRAZA, a drug given via spinal injection. Researchers will measure changes in motor function, like sitting, standing, and arm movement, over 27 months. The goal is to see if the drug helps maintain or improve physical abilities in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHP
Paris, Île-de-France Region, 94000, France
-
CHRU de Lille
Lille, Hauts-de-France, 59000, France
-
CHU de Lyon
Lyon, Auvergne-Rhône-Alpes, 69677, France
-
CHU de Montpellier
Montpellier, Occitanie, 34090, France
-
CHU de Nice
Nice, Provence-Alpes-Côte d'Azur Region, 06000, France
-
CHU de Toulouse
Toulouse, Occitanie, 31059, France
-
Hopital de la Timone - APHM
Marseille, Provence-Alpes-Côte d'Azur Region, 13005, France
Conditions
Explore the condition pages connected to this study.